Acadia Healthcare Company, Inc. (ACHC) recently inaugurated its new acute care hospital in Mesa, AZ. The new facility, Agave Ridge Behavioral Hospital, is equipped with 100 beds. Once the hospital concludes its final preparations to become fully operational, admissions of patients are expected to commence.This new facility will provide a comprehensive suite of inpatient behavioral healthcare services for treating the adult, older adult and pediatric patient populace grappling with acute symptoms of bipolar ...

Acadia Healthcare Company, Inc. (ACHC) is well positioned for growth on the back of improving patient volumes, admissions, commercial business and growing demand for behavioral health and substance use treatments. The company is actively bolstering its capabilities to address the increasing demand in these critical areas.Acadia Healthcare, with a market capitalization of $7 billion, operates as a prominent behavioral healthcare services provider in the United States and Puerto Rico. With solid prospects, th ...

Acadia Healthcare Company, Inc. (ACHC) initiated a groundbreaking collaboration with Uber Health to address the critical issue of access to behavioral health care and addiction treatment. By leveraging Uber's transportation services, Acadia aims to streamline the process for patients, ensuring they can commence treatment promptly and efficiently.Enhancing Treatment AccessibilityThe primary focus of this collaboration is on Acadia's network of Comprehensive Treatment Centers (CTCs), which specialize in medic ...

Core Insights - Acadia Healthcare Company, Inc. has recently acquired three comprehensive treatment centers in North Carolina, enhancing its footprint in the state [1][2][3] - The newly acquired centers will provide medication-assisted treatment programs combined with behavioral therapy and support services for opioid addiction [1][2] - Acadia Healthcare's revenue from comprehensive treatment centers reached $500.2 million in 2023, reflecting a 19.1% year-over-year increase, and these centers accounted for 17% of the company's overall revenue [4] Expansion Strategy - The acquisition aligns with Acadia's strategy to expand its presence in North Carolina, where it now operates 10 centers, and aims to open up to 14 additional centers in 2024 [2][4] - The company is also involved in joint ventures with U.S. health systems to add approximately 800 beds through new and existing facilities in 2024 [4] Market Context - The ongoing opioid use disorder crisis is expected to sustain demand for Acadia's treatment centers, indicating a favorable market environment for the company's services [2][4] - Acadia's stock performance has been less favorable compared to the industry, with shares rising 8.9% over the past six months, while the industry saw a growth of 36.1% [4]

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present at the Barclays 26th Annual Global Healthcare Conference, which is being held March 12 - 14, 2024, in Miami, Florida. In connection with the conference, there will be a webcast of the Company’s presentation available on the Company’s website starting at 10:45 a.m. Eastern Time/9:45 a.m. Central Time on Wednesday, March 13, 2024. The live webcast of the presentation will be availabl ...

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Q4 2023 Earnings Conference Call February 28, 2024 8:00 AM ET Company Participants Gretchen Hommrich - Vice President-Investor Relations Chris Hunter - Chief Executive Officer Heather Dixon - Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners A.J. Rice - UBS Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Scott Fidel - Stephens Sarah James - Cantor Fitzgerald Pito Chickering - Deutsche Bank Operator Good day, and welc ...

Acadia Healthcare Company, Inc. (ACHC) reported fourth-quarter 2023 adjusted earnings of 85 cents per share, which beat the Zacks Consensus Estimate by 6.3%. The bottom line improved 21.4% year over year.Total revenues amounted to $742.8 million, which advanced 10% year over year. The top line outpaced the consensus mark by 1.9%.The quarterly results benefited on the back of improved patient volumes and expansion initiatives. Solid demand for behavioral health and substance use treatment led to the increase ...

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.70 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6.25%. A quarter ago, it was expected that this provider of inpatient behavioral health care services would post earnings of $0.88 per share when it actually produced earnings of $0.91, delivering a surprise of 3 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 ACADIA HEALTHCARE COMPANY, INC. (Exact name of registrant as specified in its charter) Delaware 45-2492228 (State or other jur ...

Revenue Growth - Revenue for Q4 2023 totaled $742.8 million, a 10.0% increase compared to Q4 2022[2] - Revenue for Q4 2023 increased to $742.8 million, up 10% from $675.3 million in Q4 2022[21] - Full-year 2023 revenue reached $2.93 billion, a 12.2% increase from $2.61 billion in 2022[21] - Revenue for the year ended December 31, 2023, grew by 12.0% to $2.897 billion compared to $2.588 billion in 2022[27] - Same facility revenue increased by 10.3% in Q4 2023, driven by a 7.1% rise in revenue per patient day and a 2.9% increase in patient days[2] - Same facility revenue grew by 10.3% in Q4 2023, reaching $736.24 million compared to $667.76 million in Q4 2022[27] - Revenue per patient day rose by 6.5% to $954 in 2023, up from $896 in 2022, reflecting better pricing and service mix[27] Adjusted EBITDA and Profitability - Adjusted EBITDA for Q4 2023 was $169.6 million, up 11.9% year-over-year, excluding PRF income and a $5.9 million unfavorable adjustment in 2022[2] - Adjusted EBITDA for Q4 2023 was $171.6 million, up from $150.9 million in Q4 2022, with a margin of 23.1%[31] - Adjusted EBITDA excluding income from provider relief fund for Q4 2023 was $169.6 million, with a margin of 22.8%[31] - Adjusted EBITDA margin improved by 60 basis points to 29.1% in 2023, driven by operational efficiencies and cost management[27] - Adjusted EBITDA margin excluding provider relief funds increased by 120 basis points to 28.9% in 2023, highlighting core profitability improvements[27] - Adjusted income attributable to Acadia Healthcare Company, Inc. for Q4 2023 was $79.8 million, compared to $68.1 million in Q4 2022[34] - Adjusted income per diluted share for Q4 2023 was $0.87, up from $0.74 in Q4 2022[34] Net Income and Loss - Net income for Q4 2023 was $57.7 million, a 5.6% decrease from $61.1 million in Q4 2022[21] - Full-year 2023 net loss was $21.7 million, compared to a net income of $273.1 million in 2022[21] - Net income attributable to Acadia Healthcare Company, Inc. for Q4 2023 was $57.7 million, compared to $61.1 million in Q4 2022[31] Expansion and Acquisitions - The company added 98 beds to existing facilities in Q4 2023, bringing the total new beds added in 2023 to 302, with plans to add over 400 beds in 2024[5] - Acadia opened two comprehensive treatment centers (CTCs) in Q4 2023, meeting its goal of six CTCs for the year, and plans to open up to 14 new CTCs in 2024[6] - A new joint venture with Ascension Seton in Austin, Texas, was announced in January 2024, with the facility expected to open later in the year[7] - The company closed the acquisition of Turning Point Centers, a 76-bed specialty provider in Utah, on February 22, 2024[7] - Acadia plans to add approximately 1,200 beds in 2024, excluding acquisitions, as part of its expansion strategy[13] Financial Guidance - Full-year 2024 revenue guidance is projected to be between $3.18 billion and $3.25 billion, with Adjusted EBITDA expected to range from $730 million to $770 million[13] - Q1 2024 revenue guidance is estimated at $775 million to $785 million, with Adjusted EBITDA projected to be between $170 million and $175 million[14] Operational Metrics - Patient days increased by 5.1% to 3.036 million in 2023 from 2.889 million in 2022, indicating higher facility utilization[27] - Admissions increased by 4.9% to 194,215 in 2023, compared to 185,218 in 2022, showing growth in patient volume[27] Financial Position - Total assets increased to $5.36 billion in 2023, up 7.4% from $4.99 billion in 2022[23] - Cash and cash equivalents grew to $100.1 million in 2023, a 2.5% increase from $97.6 million in 2022[23] - Long-term debt decreased to $1.34 billion in 2023, down 1.6% from $1.36 billion in 2022[23] - Total equity slightly decreased to $2.78 billion in 2023, down 1.1% from $2.81 billion in 2022[23] - Cash and cash equivalents at the end of 2023 stood at $100.07 million, up from $97.65 million at the beginning of the year[25] Expenses - Salaries, wages, and benefits expenses rose to $1.57 billion in 2023, up 12.8% from $1.39 billion in 2022[21] - Depreciation and amortization expenses increased to $132.3 million in 2023, up 12.4% from $117.8 million in 2022[21] - Depreciation and amortization for Q4 2023 was $35.4 million, compared to $30.1 million in Q4 2022[31] - Interest expense, net for Q4 2023 was $20.5 million, up from $19.4 million in Q4 2022[31] - Legal settlements expense for the year ended December 31, 2023, was $394.2 million, primarily related to the Desert Hills litigation[34] - Non-cash impairment charges for Q4 2023 totaled $1.1 million, related to the closure of certain facilities[41] Cash Flow - Net cash provided by operating activities increased to $462.34 million in 2023 from $380.57 million in 2022, reflecting improved operational efficiency[25] - Net cash used in investing activities decreased to $397.22 million in 2023 from $305.83 million in 2022, primarily due to lower capital expenditures[25] Share Information - Weighted-average shares outstanding - diluted for Q4 2023 was 91.9 million[34]